Open Targets: a platform for therapeutic target identification and validation
about
The ChEMBL database in 2017Harnessing public domain data to discover and validate therapeutic targets.Literature evidence in open targets - a target validation platformIn silico prediction of novel therapeutic targets using gene-disease association data.SciLite: a platform for displaying text-mined annotations as a means to link research articles with biological data.Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach.Expression Atlas: gene and protein expression across multiple studies and organisms.Drug target ontology to classify and integrate drug discovery data.Enhancing the Promise of Drug Repositioning through Genetics.Computer simulation models as a tool to investigate the role of microRNAs in osteoarthritis.Pharmacogenomics of GPCR Drug Targets.Trends in GPCR drug discovery: new agents, targets and indications.Evidence-Based Precision Oncology with the Cancer Targetome.The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis.Polysaccharide from Angelica sinensis protects H9c2 cells against oxidative injury and endoplasmic reticulum stress by activating the ATF6 pathway.The 24th annual Nucleic Acids Research database issue: a look back and upcoming changes.Worldwide Protein Data Bank validation information: usage and trends.Multiclass classification for skin cancer profiling based on the integration of heterogeneous gene expression series.Sequential regulatory activity prediction across chromosomes with convolutional neural networks.Connecting genetics and gene expression data for target prioritisation and drug repositioning.Changing Trends in Computational Drug Repositioning.Genetic-Driven Druggable Target Identification and ValidationUncovering new disease indications for G-protein coupled receptors and their endogenous ligandsEditorial: Drug Repositioning: Current Advances and Future PerspectivesSearching the overlap between network modules with specific betweeness (S2B) and its application to cross-disease analysisDual Inhibitors of PARPs and ROCKs
P2860
Q28584450-4C6C0742-0B21-4052-8131-D7A6CE31BDBCQ30491667-8436C03A-65BC-4A83-8657-CE7002D41FF4Q30491914-5CD640F7-311C-40C1-9609-CBF207AECCB4Q38603369-4D09D2D7-B7D9-49A4-9DE5-9B4BB74C5D02Q41695166-2AADED4E-4C93-4350-AF7A-BC39B700F99FQ42266399-D0511398-42FE-4358-AAB7-7CE7E7B4533EQ46256149-19E97483-8DBD-4B4F-8810-445312DC7885Q46264677-9844694C-1E48-4F50-A24E-788F1B71B376Q47095277-E7B21F6A-E703-4A12-9410-33E1E35A2987Q47161268-AC70B91B-FE61-48BD-B299-E550A90C1327Q47284414-110A6B96-5F60-405E-A705-1C91A753F589Q47597808-6283C26E-15BC-490B-AB68-557A45F9441DQ47893147-12EABBDB-9467-4728-83E6-CE1A8B831859Q52563269-83B1403E-906D-4914-9772-54A575F1CABEQ52666885-6D90D4A0-137D-41F6-86A4-5CE2A7EE0B9AQ53126060-EE11161C-17E4-4B37-8168-B9ECC464B354Q55037606-744169B9-88CE-4581-832D-6190147A0DBEQ55078045-2C63BA7A-928A-4659-935C-64831954AB6AQ55092675-E0DE8F7A-F18E-4EEC-AED2-5DAD5B9FB70FQ55285352-90A1ACA4-5271-457F-B8A4-1F48A94FC5E1Q55717464-E6088EE3-EF0C-425D-BCAA-4A75460C10E1Q56022528-6248E1A1-F03B-47A4-904B-307BF5AF72E2Q57052680-63AF3328-70EE-4B37-AC15-106BB54A08D6Q57191805-8F3479E2-3463-42E0-9911-7B6406A92B66Q58051447-67735514-A82E-47A6-971D-D119C4CA009EQ58581240-D8095361-E7ED-4816-93F6-5659EB9D16A2
P2860
Open Targets: a platform for therapeutic target identification and validation
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Open Targets: a platform for therapeutic target identification and validation
@en
Open Targets: a platform for therapeutic target identification and validation.
@nl
type
label
Open Targets: a platform for therapeutic target identification and validation
@en
Open Targets: a platform for therapeutic target identification and validation.
@nl
prefLabel
Open Targets: a platform for therapeutic target identification and validation
@en
Open Targets: a platform for therapeutic target identification and validation.
@nl
P2093
P2860
P50
P356
P1476
Open Targets: a platform for therapeutic target identification and validation
@en
P2093
A Patrícia Bento
Andrea Pierleoni
Brendan Vaughan
Catherine Leroy
Edward Turner
Francisco-Javier Lopez
Gautier Koscielny
Justin Paschall
Luca Fumis
Michael Maguire
P2860
P304
P356
10.1093/NAR/GKW1055
P407
P50
P577
2016-11-29T00:00:00Z